Logo image of ALKLH.PA

KLEA HOLDING (ALKLH.PA) Stock Fundamental Analysis

EPA:ALKLH - FR0013481835 - Common Stock

0.2275 EUR
+0 (+1.11%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, ALKLH scores 4 out of 10 in our fundamental rating. ALKLH was compared to 59 industry peers in the Health Care Equipment & Supplies industry. ALKLH has only an average score on both its financial health and profitability. While showing a medium growth rate, ALKLH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ALKLH had negative earnings in the past year.
ALKLH had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ALKLH reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: ALKLH reported negative operating cash flow in multiple years.
ALKLH.PA Yearly Net Income VS EBIT VS OCF VS FCFALKLH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

ALKLH's Return On Assets of 3.71% is in line compared to the rest of the industry. ALKLH outperforms 59.32% of its industry peers.
With a Return On Equity value of 5.03%, ALKLH perfoms like the industry average, outperforming 47.46% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.21%, ALKLH is in line with its industry, outperforming 44.07% of the companies in the same industry.
Industry RankSector Rank
ROA 3.71%
ROE 5.03%
ROIC 4.21%
ROA(3y)-2.81%
ROA(5y)-21.14%
ROE(3y)-4.32%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALKLH.PA Yearly ROA, ROE, ROICALKLH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

1.3 Margins

The Profit Margin of ALKLH (8.14%) is better than 62.71% of its industry peers.
With a Operating Margin value of 9.65%, ALKLH perfoms like the industry average, outperforming 54.24% of the companies in the same industry.
ALKLH has a Gross Margin of 95.14%. This is amongst the best in the industry. ALKLH outperforms 96.61% of its industry peers.
ALKLH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.65%
PM (TTM) 8.14%
GM 95.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.3%
GM growth 5Y22.31%
ALKLH.PA Yearly Profit, Operating, Gross MarginsALKLH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

5

2. Health

2.1 Basic Checks

ALKLH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ALKLH has more shares outstanding
ALKLH has more shares outstanding than it did 5 years ago.
ALKLH has a better debt/assets ratio than last year.
ALKLH.PA Yearly Shares OutstandingALKLH.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ALKLH.PA Yearly Total Debt VS Total AssetsALKLH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 4.47 indicates that ALKLH is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.47, ALKLH belongs to the best of the industry, outperforming 84.75% of the companies in the same industry.
The Debt to FCF ratio of ALKLH is 34.84, which is on the high side as it means it would take ALKLH, 34.84 years of fcf income to pay off all of its debts.
ALKLH has a Debt to FCF ratio (34.84) which is in line with its industry peers.
A Debt/Equity ratio of 0.15 indicates that ALKLH is not too dependend on debt financing.
ALKLH has a better Debt to Equity ratio (0.15) than 81.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 34.84
Altman-Z 4.47
ROIC/WACC0.56
WACC7.55%
ALKLH.PA Yearly LT Debt VS Equity VS FCFALKLH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 1.35 indicates that ALKLH should not have too much problems paying its short term obligations.
With a Current ratio value of 1.35, ALKLH is not doing good in the industry: 61.02% of the companies in the same industry are doing better.
A Quick Ratio of 1.35 indicates that ALKLH should not have too much problems paying its short term obligations.
ALKLH has a Quick ratio of 1.35. This is in the better half of the industry: ALKLH outperforms 69.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
ALKLH.PA Yearly Current Assets VS Current LiabilitesALKLH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 260.87% over the past year.
The Revenue has grown by 25.93% in the past year. This is a very strong growth!
Measured over the past years, ALKLH shows a quite strong growth in Revenue. The Revenue has been growing by 11.01% on average per year.
EPS 1Y (TTM)260.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)25.93%
Revenue growth 3Y34%
Revenue growth 5Y11.01%
Sales Q2Q%28.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to grow by 24.27% on average over the next years. This is a very strong growth
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year34.18%
Revenue Next 2Y24.27%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALKLH.PA Yearly Revenue VS EstimatesALKLH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M 25M
ALKLH.PA Yearly EPS VS EstimatesALKLH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2025 2026 0 -2 -4 -6 -8 -10

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Forward Earnings ratio of 22.09 indicates a rather expensive valuation of ALKLH.
ALKLH's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ALKLH is cheaper than 62.71% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.72. ALKLH is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 22.09
ALKLH.PA Price Earnings VS Forward Price EarningsALKLH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALKLH is valued a bit more expensive than 64.41% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALKLH is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 421.44
EV/EBITDA 34.99
ALKLH.PA Per share dataALKLH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.02 0.04 0.06 0.08

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALKLH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KLEA HOLDING

EPA:ALKLH (8/29/2025, 7:00:00 PM)

0.2275

+0 (+1.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-21 2025-07-21
Earnings (Next)N/A N/A
Inst Owners1.29%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap69.96M
Analysts86.67
Price Target0.51 (124.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 22.09
P/S 4.05
P/FCF 421.44
P/OCF 75.06
P/B 2.5
P/tB 24.87
EV/EBITDA 34.99
EPS(TTM)0
EYN/A
EPS(NY)0.01
Fwd EY4.53%
FCF(TTM)0
FCFY0.24%
OCF(TTM)0
OCFY1.33%
SpS0.06
BVpS0.09
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.71%
ROE 5.03%
ROCE 5.12%
ROIC 4.21%
ROICexc 4.68%
ROICexgc 33.31%
OM 9.65%
PM (TTM) 8.14%
GM 95.14%
FCFM 0.96%
ROA(3y)-2.81%
ROA(5y)-21.14%
ROE(3y)-4.32%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.3%
GM growth 5Y22.31%
F-Score6
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 34.84
Debt/EBITDA 1.96
Cap/Depr 189.6%
Cap/Sales 4.44%
Interest Coverage 250
Cash Conversion 45.02%
Profit Quality 11.81%
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z 4.47
F-Score6
WACC7.55%
ROIC/WACC0.56
Cap/Depr(3y)158.1%
Cap/Depr(5y)N/A
Cap/Sales(3y)20.55%
Cap/Sales(5y)13.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.93%
Revenue growth 3Y34%
Revenue growth 5Y11.01%
Sales Q2Q%28.36%
Revenue Next Year34.18%
Revenue Next 2Y24.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y618.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year310%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y111.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.11%
OCF growth 3YN/A
OCF growth 5YN/A